Literature DB >> 894077

Encephalitis in ferrets caused by a nonproductive strain of measles virus (D.R.) isolated from patient with subacute sclerosing panencephalitis.

H Thormar, K Arnesen, P D Mehta.   

Abstract

A nonproductive, syncytiogenic strain (D.R.) of measles virus, isolated from a patient with subacute sclerosing panencephalitis (SSPE), was inoculated intracerebrally into ferrets in an attempt to induce subacute encephalitis. Inoculation of freeze-thawed syncytia before immunization was the least effective procedure, and inoculation of live syncytia after immunization with measles virus vaccine was the most effective procedure, for induction of subacute or persistent subclinical encephalitis in the animals. After the latter procedure three of five ferrets developed subacute or subclinical encephalitis, whereas ferrets inoculated with live syncytia without prior immunization consistently contracted acute fatal encephalitis in one to two weeks. The subacute encephalitis in ferrets was characterized by high titers of antibody to measles virus in serum. At the time of sacrifice 1.25, 4.5, or 8.0 months after inoculation, brains of the ferrets showed histologic lesions similar to those characteristic of SSPE, and nonproductive syncytiogenic measles virus was recovered from the brains of two of the animals. All three ferrets had greatly increased concentrations of gamma-globulin in their brains and high levels of neutralizing and hemagglutination-inhibiting antibodies to measles virus. Only one of these animals developed clinical signs 1.25 months after inoculation.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 894077     DOI: 10.1093/infdis/136.2.229

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

1.  Comparison of the neuropathogenicity of two SSPE sibling viruses of the Osaka-2 strain isolated with Vero and B95a cells.

Authors:  Nobuhisa Ito; Minoru Ayata; Masashi Shingai; Kyoko Furukawa; Toshiyuki Seto; Isamu Matsunaga; Michinari Muraoka; Hisashi Ogura
Journal:  J Neurovirol       Date:  2002-02       Impact factor: 2.643

2.  Pathogenesis of viral encephalitis: demonstration of viral antigen(s) in the brain endothelium.

Authors:  H M Wisniewski; H R Brown; H Thormar
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

3.  Immunological studies of subacute measles encephalitis in ferrets: similarities to human subacute sclerosing panencephalitis.

Authors:  P D Mehta; H Thormar
Journal:  J Clin Microbiol       Date:  1979-05       Impact factor: 5.948

4.  Measles virus matrix protein gene expression in a subacute sclerosing panencephalitis patient brain and virus isolate demonstrated by cDNA hybridization and immunocytochemistry.

Authors:  H R Brown; N L Goller; H Thormar; R Rudelli; W W Tourtellotte; P Shapshak; R Boostanfar; H M Wisniewski
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

5.  The F gene of the Osaka-2 strain of measles virus derived from a case of subacute sclerosing panencephalitis is a major determinant of neurovirulence.

Authors:  Minoru Ayata; Kaoru Takeuchi; Makoto Takeda; Shinji Ohgimoto; Seiichi Kato; Luna Bhatta Sharma; Miyuu Tanaka; Mitsuru Kuwamura; Hiroshi Ishida; Hisashi Ogura
Journal:  J Virol       Date:  2010-08-18       Impact factor: 5.103

6.  Restriction of virus-specific protein synthesis in a persistent paramyxovirus infection.

Authors:  S J Robbins; F Rapp
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

7.  Presence of oligoclonal immunoglobulin G bands and lack of matrix protein antibodies in cerebrospinal fluids and sera of ferrets with measles virus encephalitis.

Authors:  H Thormar; P D Mehta; F H Lin; H R Brown; H M Wisniewski
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

8.  Comparison of wild-type and subacute sclerosing panencephalitis strains of measles virus. Neurovirulence in ferrets and biological properties in cell cultures.

Authors:  H Thormar; P D Mehta; H R Brown
Journal:  J Exp Med       Date:  1978-09-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.